NCT04594811 2024-08-16NT-I7 in Combination With Nivolumab in Advanced Gastric, Gastro-Esophageal Junction or Esophageal AdenocarcinomaNeoImmuneTechPhase 1 Terminated10 enrolled
NCT04984811 2024-03-05NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLCNeoImmuneTechPhase 2 Active not recruiting83 enrolled